Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time
Abstract Background Tuberculosis (TB) is an infectious disease. During TB, regulatory T cells (Treg) are related to poor prognosis. However, information about conventional and unconventional Treg (cTreg and uTreg, respectively) is limited. The tumour necrosis factor (TNF) and its receptors (TNFR1 an...
Main Authors: | Norma A. Téllez-Navarrete, Lucero A. Ramon-Luing, Marcela Muñoz-Torrico, Mario Preciado-García, Karen Medina-Quero, Rogelio Hernandez-Pando, Leslie Chavez-Galan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-021-00320-4 |
Similar Items
-
<i>Mycobacterium tuberculosis</i> H37Rv Strain Increases the Frequency of CD3<sup>+</sup>TCR<sup>+</sup> Macrophages and Affects Their Phenotype, but Not Their Migration Ability
by: Lucero A. Ramon-Luing, et al.
Published: (2021-12-01) -
The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
by: Nurul Hakimah Mohd Salim, et al.
Published: (2023-01-01) -
Virulence Factors of <i>Mycobacterium tuberculosis</i> as Modulators of Cell Death Mechanisms
by: Lucero A. Ramon-Luing, et al.
Published: (2023-06-01) -
Drug hypersensitivity in drug-resistant tuberculosis
by: Zeynep Yegin Katran, MD, et al.
Published: (2023-05-01) -
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
by: Juliane Medler, et al.
Published: (2022-05-01)